Esperion Therapeutics Inc (ESPR)
2.17
+0.02
(+0.93%)
USD |
NASDAQ |
Jan 07, 16:00
2.17
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Shareholders Equity (Quarterly): -370.21M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
| Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 314.11M |
| Total Liabilities (Quarterly) | 684.32M |
| Debt to Equity Ratio | -0.7102 |
| Current Ratio | 1.854 |
| Net Debt Paydown Yield | -0.14% |